Formulation of carteolol chitosomes for ocular delivery: formulation optimization, ex-vivo permeation, and ocular toxicity examination

References

• Ameeduzzafar, Ali J, Bhatnagar A, Kumar N, Ali A. Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits. Int J Biol Macromol 2014;65:479–491.
   PubMed Web of Science ®Google Scholar
• Ameeduzzafar, Alruwaili NK, Imam SS, Alotaibi NH, et al. Formulation of chitosan polymeric vesicles of ciprofloxacin for ocular delivery: Box-Behnken optimization, in vitro characterization, HET-CAM irritation, and antimicrobial assessment. AAPS PharmSciTech 2020;21:167.
   PubMed Web of Science ®Google Scholar
• Baig MS, Ahad A, Aslam M, et al. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity. Int J Biol Macromol 2016;85:258–270.
   PubMed Web of Science ®Google Scholar
• Ameeduzzafar, Ali J, Khan N, Ali A. Development and optimization of carteolol loaded carboxymethyl tamarind kernel polysaccharide nanoparticles for ophthalmic delivery: Box-Behnken design, in vitro. Sci Adv Mater 2014;6:63–75.
   Web of Science ®Google Scholar
• Cedrone C, Mancino R, Cerulli A, Cesareo M, Nucci C. Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects. Progress in Brain Research 2008;173:3–14.
   PubMed Web of Science ®Google Scholar
• Gooch N, Molokhia SA, Condie R, et al. Ocular drug delivery for glaucoma management. Pharmaceutics 2012;4:197–211.
   PubMedGoogle Scholar
• Quigley H, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262–267.
   PubMed Web of Science ®Google Scholar
• Ameeduzzafar, Ali J, Ali A. Development and validation of UPLC/ESI-Q-TOF-MS for carteolol in aqueous humour: Stability, stress degradation and application in pharmacokinetics of nanoformulation. Arabian J Chem 2017;10:S2969–S2978.
   Web of Science ®Google Scholar
• Tetyczka C, Griesbacher M, Absenger-Novak M, et al. Development of nanostructured lipid carriers for intraoral delivery of domperidone. Int J Pharm 2017;526:188–198.
   PubMed Web of Science ®Google Scholar
• Kiss EL, Berkó S, Gácsi A, et al. Digitoxin metabolism by rat liver microsomes. Biochem Pharmacol 2019;24:1639–1641.
   Google Scholar
• Khan N, Ameeduzzafar, Khanna K, et al. Chitosan coated PLGA nanoparticles amplify the ocular hypotensive effect of forskolin: statistical design, characterization and in vivo studies. Int J Biol Macromol 2018;116:648–663.
   PubMed Web of Science ®Google Scholar
• Kalam MA, Sultana Y, Ali A, et al. Part I: development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin. J Biomed Mater Res A 2013; 1813–1827.
   PubMed Web of Science ®Google Scholar
• Henness S, Harrison TS, Keating GM. Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension. Drugs Aging 2007;24:509–528.
   PubMed Web of Science ®Google Scholar
• Akhter S, Talegaonkar S, Khan ZI, et al. Assessment of ocular pharmacokinetics and safety of ganciclovir loaded nanoformulations. J Biomed Nanotechnol 2011;7:144–145.
   PubMed Web of Science ®Google Scholar
• Zubairu Y, Negi LM, Iqbal Z, Talegaonkar S. Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: in-vitro and ex-vivo investigations. Asian J Pharm Sci 2014;10:322–330.
   Web of Science ®Google Scholar
• Abdelkader H, Fathalla Z, Moharram H, et al. Cyclodextrin enhances corneal tolerability and reduces ocular toxicity caused by diclofenac. Oxid Med Cell Longev 2018;2018:5260976.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov Today 2008;13:144–151.
   PubMed Web of Science ®Google Scholar
• Vandamme TF, Brobeck L. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J Control Release 2005;102:23–38.
   PubMed Web of Science ®Google Scholar
• Lou J, Hu W, Tian R, et al. Optimization and evaluation of a thermoresponsive ophthalmic in situ gel containing curcumin-loaded albumin nanoparticles. Int J Nanomedicine 2014;9:2517–2525.
   PubMed Web of Science ®Google Scholar
• Ding S. Recent developments in ophthalmic drug delivery. Pharm Sci Technol Today 1998;1:328–335.
   Google Scholar
• Abdelbary G. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm Dev Technol 2011;16:44–56.
   PubMed Web of Science ®Google Scholar
• Gan L, Han S, Shen J, et al. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability. Int J Pharm 2010;396:179–187.
   PubMed Web of Science ®Google Scholar
• Hao J, Fang X, Zhou Y, et al. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. Int J Nanomedicine 2011;6:683–692.
   PubMed Web of Science ®Google Scholar
• Lakhani P, Patil A, Taskar P, et al. Curcumin-loaded nanostructured lipid carriers for ocular drug delivery: design optimization and characterization. J Drug Deliv Sci Technol 2018;47:159–166.
   PubMed Web of Science ®Google Scholar
• Zafar A, Alruwaili NK, Bukhari SNA, et al. Improvement of ocular efficacy of levofloxacin by bioadhesive chitosan coated PLGA nanoparticles: Box-Behnken design, in-vitro characterization, antibacterial evaluation and scintigraphy study. Iranian Journal of Pharmaceutical Research 2020;19:292–311.
   PubMed Web of Science ®Google Scholar
• Wadhwa S, Paliwal R, Rai Paliwal S, Vyas SP. Chitosan and its role in ocular therapeutics. Mini Rev Med Chem 2010;9:1639–1647.
   Web of Science ®Google Scholar
• Shaveta S, Singh J, Afzal M, et al. Development of solid lipid nanoparticle as carrier of pioglitazone for amplification of oral efficacy: formulation design optimization, in-vitro characterization and in-vivo biological evaluation. J Drug Deliv Sci Technol 2020;57:101674.
   Web of Science ®Google Scholar
• Rinaldi F, Hanieh PN, Chan LKN, et al. Digitoxin metabolism by rat liver microsomes. Biochem Pharmacol 2018;24:1639–16.
   Google Scholar
• Yasir M, Sara UVS, Chauhan I, et al. Solid lipid nanoparticles for nose to brain delivery of donepezil: formulation, optimization by Box–Behnken design, in vitro and in vivo evaluation, artificial cells. Nanomed Biotechnol 2018;46:1838–1851.
   Web of Science ®Google Scholar
• Yasir M, Sara UVS. Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation. Acta Pharm Sin B 2014;4:454–463.
   PubMed Web of Science ®Google Scholar
• Ameeduzzafar, Imam SS, SNA Bukhari, Ahmad J, et al. Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: in-vitro characterization, ocular tolerance and antibacterial activity. Int J Biol Macromol 2018;108:650–659.
   PubMed Web of Science ®Google Scholar
• Alshehri S, Imam SS, Rizwanullah M, et al. Effect of chitosan coating on PLGA nanoparticles for oral delivery of thymoquinone: in vitro, ex vivo, and cancer cell line assessments. Coatings 2021;11:1–19.
   Web of Science ®Google Scholar
• Zammataro A, Saletti R, Civiale C, et al. Simultaneous quantification of carteolol and dorzolamide in rabbit aqueous humor and ciliary body by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry. J Chromat B Anal Technol Biomed Life Sci 2010;878:807–814.
   PubMed Web of Science ®Google Scholar
• Monti D, Saccomani L, Chetoni P, et al. Effect of iontophoresis on transcorneal permeation “in vitro of two beta-blocking agents, and on corneal hydration”. Int J Pharm 2003;250:423–429.
   PubMed Web of Science ®Google Scholar
• Budai P, Lehel J, Tavaszi J, Kormos É. HET-CAM test for determining the possible eye irritancy of pesticides. Acta Vet Hung 2010;58:369–377.
   PubMed Web of Science ®Google Scholar
• Soni K, Mujtaba A, Akhter MH, et al. Optimisation of ethosomal nanogel for topical nano-CUR and sulphoraphane delivery in effective skin cancer therapy. J Microencapsul. 2020;37:91–108.
   Google Scholar
• Essa E. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian J Pharm 2010;4:227–233.
   Google Scholar
• Hashim IIA, El-Dahan MS, Yusif RM, et al. Potential use of niosomal hydrogel as an ocular delivery system for atenolol. Biol Pharm Bull 2014;37:541–551.
   PubMed Web of Science ®Google Scholar
• Yasir M, Sara UVS, Som I, et al. Nose to brain drug delivery: a novel approach through solid lipid nanoparticles. Cnanom 2016;6:105–132.
   Google Scholar
• Fetih G. Fluconazole-loaded niosomal gels as a topical ocular drug delivery system for corneal fungal infections. J Drug Delivery Sci Technol 2016;35:8–15.
   Web of Science ®Google Scholar
• Jumah MB, Gilani SJ, Jahangir MA, et al. Clarithromycin-loaded ocular chitosan nanoparticle: Formulation, optimization, characterization, ocular irritation, and antimicrobial activity. IJN 2020;15:7861–7875.
   Web of Science ®Google Scholar
• Fouda NH, Abdelrehim RT, Hegazy DA, Habib BA. Sustained ocular delivery of dorzolamide-HCL via proniosomal gel formulation: In-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits. Drug Deliv 2018;25:1340–1349.
   PubMed Web of Science ®Google Scholar